Event
February 17, 2026
12:30 - 16:00
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
CEPI leverages its unique position within the global health and R&D ecosystems to address market failures, building on its track record of bringing together public-sector, private-sector, and academic partners to accelerate the development of vaccines against emerging viral threats.
CEPI supports the development of vaccines, platform technologies and manufacturing innovations to combat priority pathogens for which no licensed vaccines are currently available.
CEPI is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk.
CEPI has backed the development of 30+ vaccine candidates for its priority pathogens, overseeing scientific breakthroughs, including the first-ever approved Chikungunya vaccine, and advancing the first-ever Nipah vaccine into Phase I and the first-ever Lassa fever vaccine into Phase II trials. A key player in the COVID-19 response, CEPI also has one of the world’s largest COVID-19 vaccine portfolios and co-led COVAX, which helped to distribute nearly 2 billion doses to 146 nations.
The event aims at unveiling the new CEPI 3.0 strategy (2027-2031) – bold vision to accelerate pandemic preparedness and strengthen global health security.
Senior CEPI leadership will be exploring how CEPI 3.0 builds on a proven track record to deliver improved, globally accessible vaccines and technologies, safeguarding preparedness and resilience in today’s rapidly changing landscape.
This event would like to offer Swiss stakeholders a platform for potential future collaborations
Name
coming
soon
Name
coming
soon
Name
coming
soon
Name
coming
soon
Name
coming
soon
| First meeting with permanent missions | |
| 12:30 – 13:15 | Presentation by CEPI followed by a Q&A session |
| 13:15 – 14:00 | Light Lunch |
| Second meeting with scientific and industrial stakeholders | |
| 14:30 – 15:15 | Presentation by CEPI followed by a Q&A session |
| 15:15 – 16:00 | Coffee |
A first meeting, from 12:30 to 14:00, will be dedicated to representatives of the Permanent Missions in Geneva.
The objective is to present CEPI’s strategy for accelerating the development of new vaccines and to highlight CEPI’s role as a key stakeholder in global preparedness and response to future pandemics.
A second meeting, from 14:30 to 16:00, will be open to universities, researchers, and companies involved in infectious diseases and vaccine development.
This session aims to provide Swiss scientific and industrial stakeholders with a platform to explore potential future collaborations with CEPI.
Registration is free but mandatory
Created by
